10-97320228-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005479.4(FRAT1):c.775G>A(p.Asp259Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000311 in 1,605,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005479.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAT1 | NM_005479.4 | c.775G>A | p.Asp259Asn | missense_variant | 1/1 | ENST00000371021.5 | NP_005470.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAT1 | ENST00000371021.5 | c.775G>A | p.Asp259Asn | missense_variant | 1/1 | 6 | NM_005479.4 | ENSP00000360060.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151974Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000436 AC: 1AN: 229522Hom.: 0 AF XY: 0.00000794 AC XY: 1AN XY: 125974
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1453260Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 722416
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151974Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74224
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.775G>A (p.D259N) alteration is located in exon 1 (coding exon 1) of the FRAT1 gene. This alteration results from a G to A substitution at nucleotide position 775, causing the aspartic acid (D) at amino acid position 259 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at